FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Avella of Deer Valley, Inc. Store 38 Bevacizumab 2 Recall

Bevacizumab 2

Avella of Deer Valley, Inc. Store 38 · Phoenix, AZ

Risk level
Class II
Reported by FDA
Jun 5, 2019
Recall ID
D-1308-2019
Check your lot numberHow we source this data

Summary

Avella of Deer Valley, Inc. Store 38 recalled Bevacizumab 2 starting May 3, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1308-2019 on Jun 5, 2019. Reason: Lack of assurance of sterility. Status: Terminated.

Why it was recalled

Lack of assurance of sterility

Product description

Bevacizumab 2.5 mg/0.1 mL, packaged in a Prefilled Syringe, Rx only, AVELLA SPECIALTY PHARMACY 24416 N. 19TH AVENUE PHOENIX, AZ 85085, NDC 42852-001-27

Lot numbers, UPCs & expiration codes

Lot #: 138-20191202@64, Exp 05/13/19

Where it was sold

U.S.A. nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1308-2019
Classification
Class II
Status
Terminated
Recall initiated
May 3, 2019
FDA report date
Jun 5, 2019
Quantity
730 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Avella of Deer Valley, Inc. Store 38

Original FDA data

Every field from FDA enforcement report D-1308-2019, exactly as published.

Show all FDA fields
City
Phoenix
State
AZ
Status
Terminated
Country
United States
Event ID
82790
Address
24416 N 19th Ave
Code information
Lot #: 138-20191202@64, Exp 05/13/19
Postal code
85085-1887
Report date
Jun 5, 2019
Product type
Drugs
Recall number
D-1308-2019
Classification
Class II
Recalling firm
Avella of Deer Valley, Inc. Store 38
Product quantity
730 syringes
Termination date
Feb 25, 2020
Reason for recall
Lack of assurance of sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Bevacizumab 2.5 mg/0.1 mL, packaged in a Prefilled Syringe, Rx only, AVELLA SPECIALTY PHARMACY 24416 N. 19TH AVENUE PHOENIX, AZ 85085, NDC 42852-001-27
Distribution pattern
U.S.A. nationwide
Recall initiation date
May 3, 2019
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
May 29, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1308-2019, published Jun 5, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls